Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today ...

The Epithelial Thickness Module is expected to be commercially available in February 2025. According to Heidelberg ...

Glaukos has invented by all accounts the world’s smallest medical device – smaller than the dot above this “j” that you are ...

Have you ever wondered how an ophthalmologist studies your cornea in detail? It’s no longer futuristic technology from a ...

The FDA cleared the Epithelial Thickness Module for the Anterion cornea app from Heidelberg Engineering, according to a press ...

Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice ...